Search results
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 1 day agoCAR-T drugs are developed using a patient's own immune cells. Promisingly, Pfizer said in February...
This 6% Yielding Dividend Stock Could Pump Up Your Passive-Income Stream
Motley Fool via Yahoo Finance· 19 hours agoThat's more than enough to meet a dividend commitment currently set at $1.68 per share annually. In...
3 Profitable Dividend Stocks to Buy at Near-Lows
InvestorPlace· 9 hours agoWith high yields above 3% and dirt-cheap valuations, these undervalued dividend stocks present a significant margin of safety.
AstraZeneca pulls its COVID-19 vaccine from the European market
Houston Chronicle· 1 day agoThe pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine...
Got $1,000? 3 Dividend Stocks to Buy and Hold Forever
Motley Fool via Yahoo Finance· 2 days agoThere's more to this pharmaceutical giant than COVID-19 Pfizer has been an odd stock to follow for...
Forget Nvidia: These 3 Small-Cap Stocks Offer Up to 557% Upside, According to Select Wall Street...
Motley Fool via Yahoo Finance· 18 hours agoThe reason Novavax's stock chart looks so...It was one of a select few drug companies to...
Can Pfizer Challenge Lilly and Novo Nordisk in the Obesity Market?
Motley Fool via Yahoo Finance· 6 days agoIt even projects around $25 billion...additional annual revenue by 2030 from business development...
AstraZeneca withdraws COVID-19 vaccine, citing declining demand
BioPharma Dive via Yahoo Finance· 2 days agoThe move ends a turbulent saga for AstraZeneca, which successfully developed a coronavirus shot but...
Maximize Your Dividends: 7 Stocks Trading Under $50 with 5%+ Yields
InvestorPlace· 3 days agoInvesting in dividend stocks is one of the surest paths to building long-term wealth. The good news...
Revive Your Portfolio: 3 Undervalued Stocks Poised for Growth
InvestorPlace· 4 days agoWith the sharp rise in the equities space since the beginning of the year, it’s been difficult to...